ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TILS Tiziana Life Sciences Plc

58.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tiziana Life Sciences Plc LSE:TILS London Ordinary Share GB00BKWNZY55 ORD 3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 58.50 45.00 60.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Tiziana Life Sciences Share Discussion Threads

Showing 176 to 198 of 17925 messages
Chat Pages: Latest  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
12/6/2015
17:21
interesting, thanks
rovi69
12/6/2015
14:04
also, on CDK studies elsewhere:

Cyclin-dependent kinase 2 (CDK2)

andrbea
12/6/2015
13:46
'inhibitors of cyclic-dependent kinase' seem to be heavily researched just now

eg

giants like Pfizer are behind similar trials :

andrbea
10/6/2015
08:30
hxxp://meetinglibrary.asco.org/content/131226-144
Interesting read

impala391
09/6/2015
07:54
Anyone going to the AGM at end of month as I can't make it?
jpuff
04/6/2015
10:09
regarding 'anti-cancer stem cell agents', here is another company (dd. June 1st) already on phase 1&2 trials. These agents seem relevant to eg pancreatic cancer:
andrbea
22/5/2015
15:56
It must be an interesting field of research, as other firms are working in the same area (anti-cancer stem cell agents):

eg (another player):
"We are currently exploring the impact of this targeted anti-cancer stem cell agent in our Phase 2 clinical trials."

andrbea
21/5/2015
08:46
Dr Lee Campbell, Research Projects and Science Communications Manager at Cancer Research Wales, who part-fund the study, commented: "This is an exciting breakthrough as cancer stem cells are thought to be responsible for the failure of many cancer treatments and the re-emergence of cancers, often many years after the initial disease.

"Therefore the ability to eliminate cancer stem cells from the body offers the opportunity to totally eradicate stubborn and residual disease once and for all. As a charity we are proud to be associated with such ground-breaking research here in Wales and look forward to seeing how these new compounds perform in patients."

andrbea
19/5/2015
16:11
up 6.2%
the bounce is on

andrbea
18/5/2015
15:42
Falling back after a good run up. I wonder where the floor is. Probably ran ahead of itself which has spooked out those who have seen such a strong rise. Interesting company it must be said!
mach100
14/5/2015
07:04
hxxp://www.cardiff.ac.uk/news/view/100032-new-anti-cancer-stem-cell-compound-in-development
impala391
08/5/2015
10:25
Apologies Twodegrees I mis-interpreted your post. Fingers crossed for both of us now. :)
jpuff
08/5/2015
09:21
jpuff just putting some facts to the gloss...I want it to rise just like you do
twodegrees
07/5/2015
22:41
Lol, try harder
jpuff
07/5/2015
21:59
previously spun off from ADI
twodegrees
07/5/2015
21:55
do not get over excited some of us have to make over £30 a share just to break even as this new formed tils was spun off and in the process many holders had to face a consolidation that wiped out share value... so any improvement is good but long term holders will not be jumping so high for the moment.
twodegrees
07/5/2015
17:07
I like it ;) eom
jpuff
07/5/2015
16:36
still under the radar then :-)

up 25%

alliance news today
trades late on, 2 of 10k and 1 of 23k (in volume)

andrbea
07/5/2015
12:56
brilliant investment and great news today ,i don't know how high this will go but sadly for me i have no more shares left..


and the advantage of a quiet thread.

sos100
07/5/2015
09:25
Excellent news today
All looking good
Chart first class

saturn5
07/5/2015
08:55
an old post (for newcomers):

andrbea
30 Jun'14 - 15:04 - 66 of 163 0 0 edit

The new contract today is, in essence, all down to the attraction & apppeal of working with TILS' new adviser. This man has know-how that researchers want to draw on. and a history of building multi-dollar companies.

eg his CV:
For his VEGF discovery, he won a Lasker Award in 2010.[2] In 2013, he was awarded the $3 million Breakthrough Prize in Life Sciences for his work.

andrbea
07/5/2015
08:52
maybe its mkt cap is out of sync with other peer companies (in the US) researching the same thing: cyclin-dependent kinase (CDK)

up 8% today

andrbea
06/5/2015
15:44
Nice rise today. After slight pull back off highs looks good to go again - can't buy any electronically.
roper
Chat Pages: Latest  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock